z-logo
open-access-imgOpen Access
Commentary: Is it time to re-evaluate the empiric intravitreal antibiotic therapy in infectious bacterial endophthalmitis?
Author(s) -
Taraprasad Das
Publication year - 2022
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_393_22
Subject(s) - medicine , amikacin , endophthalmitis , vancomycin , vitrectomy , antibiotics , ceftazidime , gentamicin , ophthalmology , visual acuity , staphylococcus aureus , pseudomonas aeruginosa , microbiology and biotechnology , biology , genetics , bacteria

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here